Our strengths: in tune with today’s challenges

“The University is at the forefront of thinking about scientific, economic and human challenges in today’s world.”

Jean-Marie Lehn, Nobel Prize in Chemistry 1987

Some examples of concrete scientific breakthroughs achieved by Strasbourg's research teams:

Materials of the future

picto - materiaux du futur
  • A revolution for chemotherapy: nanocontainers for transporting medication, DNA or enzymes to the damaged cells
  • New-generation electroluminescent transistors to produce displays with a resolution 3,000 times better than the most powerful Retina displays
  • Self-oscillating artificial materials, similar to the living, capable of performing complex biological functions such as cell division
  • Micromachines for storing energy and information, which herald the electronics of the future and earned Jean-Pierre Sauvage a Nobel Prize in 2016
  • A new class of self-healing thermosetting and recyclable polymers (for scratches)
  • A new fluorescent coating method for instruments in minimally invasive surgery: providing more precision in the surgical procedure
  • Carbon nanomaterials as tools for biomedical innovation: modulating autoimmune diseases
  • Innovative biomaterials to fight nosocomial diseases

Environment & Renewable Energy

picto - environnement
  • The creation of insulating and waterproof polymers, and biomass packaging, which has countless industrial uses
  • Advances in the field of green chemistry, particularly for biodegrading organic pollutants
  • New nanomaterials, such as nanotubes, combined with catalyst expertise for producing and storing renewable energy
  • New catalytic methods to improve the large-scale production of anti-cancer, antitumor and hepatitis C drugs, while drastically limiting releases to levels that reduce environmental impact
  • Sustainable catalysts – recyclable and regenerative – metal-free and with a carbon-based coating for the treatment of toxic gases in the chemical and petroleum industries

Health

picto - sante
  • Medication brought to phase 3, the results of which are imminent, to cure lupus, an autoimmune disease that affects more than 5 million people
  • 10 children suffering from heart defects have already been cured thanks to Strasbourg-based research: new technology created by the European company Xeltis uses Jean-Marie Lehn’s research to make cardiovascular implants made from polymers that grow with the child, avoiding the need for multiple risky operations
  • Treating multiple sclerosis, asthma, Crohn’s disease, Sjogren syndrome, Parkinson’s and psoriasis thanks to possible medication within five years
  • Medalis helped create 6 working start-ups for effective technology transfer against cancer and inflammation thanks to a unique synergy of skills in biology, chemistry and medicine